[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363649-105":59,"doc-detail-363649-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-neuroimmune-axis-in-breast-cancer-from-mechanistic-insights-to-clinical-applications-review","The neuroimmune axis in breast cancer - from mechanistic insights to clinical applications - review","","Breast cancer is the most commonly diagnosed malignancy in women worldwide, and its heterogeneity together with the complexity of the tumor microenvironment leads to substantial variability in treatment outcomes. Evidence increasingly shows that the neuroimmune axis critically regulates breast cancer progression and therapeutic resistance. This review details bidirectional neuro-immune crosstalk, summarizes mechanisms and emerging therapies, and highlights challenges for clinical translation including biomarker standardization and spatiotemporal variability.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-neuroimmune-axis-in-breast-cancer-from-mechanistic-insights-to-clinical-applications-review/363649/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-neuroimmune-axis-in-breast-cancer-from-mechanistic-insights-to-clinical-applications-review/363649.png","ImageObject",300,407,{"name":92,"@type":93},"Aldword","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role does the neuroimmune axis play in breast cancer?","Question",{"text":113,"@type":114},"The neuroimmune axis enables bidirectional communication between the nervous and immune systems. It modulates immune cell activity and reshapes tumor behaviors, contributing to progression and treatment resistance.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which therapeutic strategies does the review discuss?",{"text":118,"@type":114},"It reviews emerging approaches including repurposing neuroactive agents, breast-targeted drug delivery systems, combining neural stimulation with immune checkpoint blockade, and microbiota–neuroimmune interventions.",{"name":120,"@type":111,"acceptedAnswer":121},"What challenges limit clinical translation of neuroimmune-targeted therapies?",{"text":122,"@type":114},"Key issues include spatiotemporal heterogeneity of neuroimmune regulation, a narrow therapeutic window for neuropharmacological agents, and lack of standardized biomarkers.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},363649,1790388030,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":24,"preview_urls":147},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Wu et al. BMC Medicine (2026) 24:360 [https://doi.org/10.1186/s12916-026-04870-4](https://doi.org/10.1186/s12916-026-04870-4)  \nBMC Medicine  \n REVIEW Open Access  \nThe neuroimmune axis in breast cancer: from mechanistic insights to clinical applications  \nYimao Wu1,2,3†, Kaiyu Zhang4†, Xinya Xia5†, Tianqi Zhang4, Naijun Jiang6, Yu Zhang7, Fangqi Zheng6, Yuhan Jiang6, Xiaorui Xiang8, Huijie Miao9, Hailin Tang10*, Shuai Ren2* and Meng-Yao Li 1,11*  \nAbstract  \nBackground Breast cancer is the most commonly diagnosed malignancy in women worldwide, and its marked heterogeneity together with the complexity of the tumor microenvironment contributes to substantial variability in therapeutic responses. Although conventional studies have mainly focused on tumor cell-intrinsic alterations, increasing evidence has identified the neuroimmune axis as a critical regulator of breast cancer progression and treatment resistance.  \nMain body The neuroimmune axis involves bidirectional crosstalk between the nervous system and the immune system, mediated by neurotransmitters, neuropeptides, and neurotrophins. These mediators modulate immune cell activity and reshape tumor behaviors, including proliferation, epithelial-mesenchymal transition, angiogenesis, and metastasis, while immune-derived cytokines can in turn remodel neural circuits and sustain a pro-tumor microenvironment. In this review, we summarize the major mechanisms underlying neuroimmune regulation in breast cancer and discuss emerging therapeutic strategies, including repurposing of neuroactive agents, breast-targeted drug delivery systems, neural stimulation combined with immune checkpoint blockade, and microbiota-neuroimmune interventions. We also outline key challenges to clinical translation, such as the spatiotemporal heterogeneity of neuroimmune regulation, the narrow therapeutic window of neuropharmacological agents, and the lack of standardized biomarkers.  \nConclusion A deeper understanding of the neuroimmune axis may provide a theoretical basis for precision therapeutic strategies and help improve outcomes, particularly in therapy-resistant subtypes such as triple-negative breast cancer.  \nKeywords Breast cancer, Neuroimmune axis, Tumor microenvironment, Neurotransmitters, Neurotrophins, Immunotherapy  \n†Yimao Wu, Kaiyu Zhang and Xinya Xia contributed equally to this work.  \n*Correspondence:  \nHailin Tang [tanghl@sysucc.org.cn](tanghl@sysucc.org.cn)[ ](tanghl@sysucc.org.cn)Shuai Ren [shuairen@njucm.edu.cn](shuairen@njucm.edu.cn)[ ](shuairen@njucm.edu.cn)Meng-Yao Li[limy@sioc.ac.cn](limy@sioc.ac.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nWu et al. BMC Medicine (2026) 24:360  \nBackground  \nCancer is not only the leading cause of death worldwide. It is also a key factor hindering the extension of life expecta","cbCaiqFYpRGSwtFa","https://ap.wps.com/l/cbCaiqFYpRGSwtFa","pdf",5746512,47,"English","# Abstract\n## Background\n# Main body\n## Bidirectional neuroimmune crosstalk and key mechanisms\n## Emerging therapeutic strategies\n## Challenges for clinical translation\n# Conclusion\n# Keywords\n# Background\n## Global burden and tumor microenvironment complexity\n## Neuroimmune crosstalk origins and oncology advances\n## Current focus areas in neuroimmune regulation","[{\"question\":\"What role does the neuroimmune axis play in breast cancer?\",\"answer\":\"The neuroimmune axis enables bidirectional communication between the nervous and immune systems. It modulates immune cell activity and reshapes tumor behaviors, contributing to progression and treatment resistance.\"},{\"question\":\"Which therapeutic strategies does the review discuss?\",\"answer\":\"It reviews emerging approaches including repurposing neuroactive agents, breast-targeted drug delivery systems, combining neural stimulation with immune checkpoint blockade, and microbiota–neuroimmune interventions.\"},{\"question\":\"What challenges limit clinical translation of neuroimmune-targeted therapies?\",\"answer\":\"Key issues include spatiotemporal heterogeneity of neuroimmune regulation, a narrow therapeutic window for neuropharmacological agents, and lack of standardized biomarkers.\"}]","The neuroimmune axis in breast cancer - from mechanistic insights to clinical applications - review | PDF",1790152408,118,[148,152,156,160,164],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f35f7ccead0d111d6a3884ca911fa725.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c1105d05d6bd3a97ea6a69fb5603943.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51077cc5ae88ed8ed4ef2060b64b3244.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/589bd920ba911113db3c122727b1b83d.webp",980,1301,{"page_no":24,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8134c05f1f9a8bddac85801bc83cc95e.webp",979,1300]